Top Suppliers:I want be here
Related CAS#:
2413986-35-1 2738333-10-1
2741870-21-1 1445901-41-6
1801197-92-1 1887161-80-9
1644029-01-5 2230779-18-5
2170477-75-3 2664106-24-3

2413986-35-1

2413986-35-1 structure
2413986-35-1 structure
  • Name: RORγt Inverse agonist 10
  • Chemical Name: RORγt Inverse agonist 10
  • CAS Number: 2413986-35-1
  • Molecular Formula: C25H26F6N6O3
  • Molecular Weight: 572.50
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease ROR
  • Create Date: 2020-08-09 13:10:46
  • Modify Date: 2024-01-04 20:40:12
  • RORγt Inverse agonist 10 is a potent and orally bioavailable RORγt (retinoic acid receptor-related orphan nuclear receptor gamma t) inverse agonist, with an IC50 of 51 nM. RORγt is a major transcription factor of genes related to psoriasis pathogenesis such as IL-17A, IL-22, and IL-23R[1]
Name RORγt Inverse agonist 10
Description RORγt Inverse agonist 10 is a potent and orally bioavailable RORγt (retinoic acid receptor-related orphan nuclear receptor gamma t) inverse agonist, with an IC50 of 51 nM. RORγt is a major transcription factor of genes related to psoriasis pathogenesis such as IL-17A, IL-22, and IL-23R[1]
Related Catalog
Target

RORγt:51 nM (IC50)

In Vitro RORγt Inverse agonist 10 has a good liver microsome stability (human CLint=0.010 mL/min/mg, mouse CLint=0.030 mL/min/mg)[1]. RORγt Inverse agonist 10 suppresses the IL-17A production in a dose-dependent manner with an IC50 of 130 nM in a human whole-blood assay[1].
In Vivo RORγt Inverse agonist 10 (3-100 mg/kg; p.o.) shows robust and dose-dependent inhibitory effect on the IL-17A production in mouse IL-18/23-induced cytokine expression model[1]. RORγt Inverse agonist 10 (1.145 mg/kg; p.o.) shows a high AUC of 15000 nM*h and t1/2 of 3.6 hours[1]. Animal Model: C57/BL6 male mice, mouse IL-18/23-induced cytokine expression model[1] Dosage: 3 mg/kg, 10 mg/kg, 30 mg/kg, 100 mg/kg Administration: Oral administration Result: Significantly inhibited the IL-17A production in a dose-dependent manner. Animal Model: Mice[1] Dosage: 1.145 mg/kg (Pharmacokinetic Analysis) Administration: Oral administration Result: AUC=15000 nM*h, t1/2=3.6 hours.
References

[1]. Ryota Nakajima, et al. Discovery of [1,2,4]Triazolo[1,5- a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists. ACS Med Chem Lett. 2020 Feb 27;11(4):528-534.
Molecular Formula C25H26F6N6O3
Molecular Weight 572.50

Chemsrc provides CAS#:2413986-35-1 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 2413986-35-1 | Chemsrc address: https://www.chemsrc.com/en/baike/1566298.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved